Teratogenic Drugs Pose Little Risk To Partners Of Male Patients, FDA Panel Says

There is little to no evidence that a teratogenic drug would pass from a man to his female partner at a high enough level to endanger a fetus, the Drug Safety and Risk Management Advisory Committee tells FDA.